1. Field of the Inventions
This application relates in general to the field of skin treatment, and more specifically to apparatuses and methods for treating a person's skin.
2. Description of the Related Art
Abrasion of the outer layer or epidermis of the skin is desirable to smooth or blend scars, blemishes, or other skin conditions that may be caused by, for example, acne, sun exposure, and aging. Standard techniques used to abrade the skin have generally been separated into two fields referred to as dermabrasion and microdermabrasion. Both techniques remove portions of the epidermis called the stratum corneum, which the body interprets as a mild injury. The body then replaces the lost skin cells, resulting in a new outer layer of skin. Additionally, despite the mild edema and erythema associated with the procedures, the skin looks and feels smoother because of the new outer layer of skin.
Dermabrasion refers to a procedure in which the surface of the skin is removed due to mechanical rubbing by a handpiece with an abrasive element that is often in the form of a burr, wheel, or disc. This process tends to be painful and messy. In fact, the procedure is sometimes painful enough to require a local anesthetic. Dermabrasion leaves the skin red and raw-looking. The removed skin can take several months to regrow and heal. Recent efforts have led to the use of lasers instead of abrasive elements, which have resulted in less bleeding, but the pain and mess remains.
Efforts have been made to decrease the mess caused by the process waste, such as removed skin and blood, by adding a suction element. As the process waste is drawn into the suction opening, skin that has not been removed is also pulled against the grit surrounding the suction opening, so the procedure remains fairly messy due to the abrasion that takes place outside of the handpiece by the grit.
Microdermabrasion refers generally to a procedure in which the surface of the skin is removed due to mechanical rubbing by a handpiece emitting a stream of sand or grit. For example, a handpiece can be used to direct an air flow containing tiny crystals of aluminum oxide, sodium chloride, or sodium bicarbonate. The momentum of the grit tends to wear away two to three cell layers of the skin with each pass of the handpiece. Alternatively, new “crystal-free” microdermabrasion techniques utilize a diamond-tipped handpiece without a stream of grit.
Efforts to add a suction element have been more successful in microdermabrasion than in dermabrasion because the handpiece applying the stream of grit is more controllable to a localized area. That is, as the removed skin is drawn into the suction opening, skin that has not been removed is also pulled towards the handpiece where it is treated with the grit stream, allowing for simultaneous local treatment and suction.
Microdermabrasion removes moisture from the skin, so the procedure is always followed by the application of moisturizing creams. However, similar to topical application of moisturizing creams prior to microdermabrasion, the moisturizing elements only work as deep as the active ingredients can passively migrate through the remaining epidermis.
According to some embodiments, a system for treating skin includes a handpiece assembly comprising a tip and a main body portion, the main body portion comprising an interior cavity and a canister configured to store at least one treatment or waste material. The treatment or waste material is in fluid communication with the tip.
In some embodiments, the system further comprises a fluid transfer device for transferring the treatment or waste material to and from the canister. In other embodiments, the system further includes a conduit configured to place the canister in fluid communication with the tip. In still other arrangements, the conduit is routed within the interior cavity of the main body portion. In another embodiment, the conduit comprises at least two passages with each passage configured to transfer a different material to or from the canister.
According to some embodiments, the handpiece assembly and the canister form a unitary structure. In alternative embodiments, the handpiece assembly and the canister are substantially separated. In one embodiment, the canister comprises at least one compartment which may be configured to contain a treatment fluid and/or waste materials. In other embodiments, the treatment fluid comprises a serum. In yet other arrangements, the tip of the handpiece assembly is removable.
These and other features, aspects and advantages of the present invention are described with reference to drawings of certain preferred embodiments, which are intended to illustrate, but not to limit, the present invention. The drawings include twenty-eight (28) figures. It is to be understood that the attached drawings are for the purpose of illustrating concepts of the present invention and may not be to scale.
With continued reference to
In arrangements where a removable tip 20 is used, the handpiece assembly 10 can include an interface portion 30 along its distal end that is configured to securely receive the tip 20. In
With continued reference to
One or more conduits 50 can be placed in fluid communication with the openings 44, 46, and thus, at least a portion of the tip 20 of the handpiece assembly 10. The conduits 50 can be configured to transfer (e.g., deliver, withdraw, etc.) fluids or other materials to and/or from the distal end of the handpiece assembly 10. As shown in
With continued reference to
With continued reference to
As illustrated in
The use of a conduit 50 that extends within an interior cavity of the handpiece assembly 10 can provide one or more advantages or benefits. For example, such designs can permit a user to easily remove, attach or replace a conduit 50 between or during a treatment or procedure. In addition, contamination of an interior of the handpiece assembly 10 can be reduced or eliminated because fluids or other substances transmitted through the handpiece assembly 10 are fully contained within the passages 54, 56 of the conduit 50.
With continued reference to
In
As illustrated in
With continued reference to
Another embodiment of a canister 200 is illustrated in
A different embodiment of a canister 200A is illustrated in
Accordingly, a user can easily and conveniently handle and manipulate the handpiece assembly 310 illustrated in
With continued reference to
Any of the embodiments of a handpiece assembly disclosed herein can comprise a tip that swivels, rotates and/or otherwise moves relative to a main body portion. Such a feature can facilitate moving and manipulating a handpiece assembly along a person's skin surface during a treatment procedure. This can be particularly significant when the treatment surface is highly contoured.
In the embodiment illustrated in
With respect to any of the embodiments discussed and/or illustrated herein, the handpiece assembly, pump or other fluid transfer device and/or any other component of the skin treatment system can be powered using one or more power sources. For example, in some embodiments, a battery (e.g., disposable, rechargeable, etc.), an AC power source (e.g., with or without a transformer) or any other power device or source can be connected, attached or otherwise supplied to the desired component or subcomponent of the treatment system. In addition, the various components or subcomponents can include one or more controllers, electrical and/or instrumentation connections, ports and/or the like, as desired or required for the proper operation of the treatment system.
According to one embodiment, the self-contained handpiece assembly 310 illustrated in
With further reference to
According to some embodiments, once the membrane 504 is punctured, the internal contents of the cartridge 500 can be in fluid communication with the tip (not shown) of a handpiece assembly. Thus, the hollow tube 516 or other penetrating member can access the internal contents of the cartridge 500 so they can be transferred through the body of the handpiece assembly to a working surface (e.g., tip). The fluids and/or other substances can be conveyed to a tip or other working surface of the handpiece assembly by gravity flow, using a pump or other fluid transfer device and/or the like. In some arrangements, as illustrated in
The membrane 504 of the cartridge 500 can include any flexible, semi-rigid or rigid materials that is adapted to be punctured by a hollow tube 516 or other member when the cartridge 500 is secured to a handpiece assembly. In some embodiments, the membrane comprises rubber, plastic and/or the like. In addition, the membrane 504 can be configured to be re-sealable once the cartridge 500 is removed from the handpiece assembly.
With reference to
As illustrated in the cutaway cross-sectional view of
The handpiece assembly 600 illustrated in
With continued reference to
When the contents of the cartridge 720 have been emptied and/or when a user wishes to use fluids and/or materials contained with a different cartridge 720, the process by which the cartridge 720 was secured within the docking area 705 can be reversed. For example, the cartridge 720 can be rotated so that the locking ear 722 or other protruding member generally aligns with the recess 706 to permit the cartridge 720 to be removed. As with other embodiments, the illustrated cartridge 720 can include an O-ring 726 or other sealing member to prevent or reduce the likelihood of leaks.
With continued reference to
With continued reference to
The pump, other fluid transfer device and/or any other electric component or features of the system can be operated by one or more power sources (e.g., AC, DC, rechargeable or disposable batteries, etc.). In addition, the handpiece assembly 700 and/or the housing 740 can include buttons, dials and/or other members that permit a user to selectively control the operation during a treatment procedure.
As discussed herein in reference to other arrangements, the cartridge 820 can include a nozzle portion with a locking ear 826 or other protruding member that is configured to engage and mate with a corresponding slot 806, recess and/or other feature of the docking area 805. Further, the nozzle of the cartridge 820 can include an O-ring 828 or other sealing member to prevent or reduce the likelihood of leaks when fluids and/or other substances are being transferred from the cartridge 820 to the tip 810. In some embodiments, the end of the nozzle portion of the cartridge comprises a membrane or other member (not shown) that can be punctured or otherwise compromised by a hollow tube 808, spike or other member when the cartridge 820 is secured within the docking area 805.
Another embodiment of a skin treatment system 900 comprising a handpiece assembly 910, a replaceable cartridge 920 and a separate base member 940 is illustrated in
In addition, the base member 940 can include a waste canister or container 960 that is adapted to receive waste fluids and other substances. As with the cartridge 920, the waste canister 960 can be configured to be selectively secured to and/or removed from the base member 940 for emptying, cleaning, replacement and/or any other purpose.
Further, in some embodiments, the base member 940 comprises one or more controls (e.g., ON-OFF switches, other switches, knobs and/or the like) for regulating the operation of the system. As shown, a power supply or other electrical connection 950 can be used to power the base member 940, a vacuum pump or other fluid transfer device contained within the base member 940 (or any other portion of the system) and/or any other electrical component or subcomponent of the system. Further, the base member 940 can comprise a recessed area 946 along its lower portion which is configured to receive one or more conduits 930, power cables and/or the like.
A tip can be configured to slidably connect to the distal end and/or any other portion of a handpiece assembly. For example, in some embodiments, the tip can be press fit onto the handpiece assembly. One or more O-rings or other sealing members can be used between adjacent surfaces of the tip and the handpiece assembly to prevent or reduce the likelihood of undesirable leaks. In other embodiments, a tip can be secured to a handpiece assembly using any other method or device, such as, for example, a threaded connection, interlocking tabs, flanges or other members, other fasteners and/or the like. In still other arrangements, the tip can be permanently or semi-permanently attached to the handpiece assembly.
In the embodiment illustrated in
As illustrated in
With continued reference to
As illustrated, the outer diameter or other comparable dimension (e.g., length, width, etc.) of the posts or other protruding members 980 can vary. In other arrangements, the diameter and/or other dimensions of the protruding members can be similar or substantiality similar. The posts or other protruding members 980 can be located, spaced and otherwise oriented along the distal end 971 of the tip 970 in any desired or required manner.
It will be appreciated that the size, shape, spacing, orientation, location and/or other properties of the protruding members 980 can be different than illustrated and disclosed herein, as desired or required by a particular procedure or application. As discussed herein, the lip member 977 of the tip 970 can help create an enclosed space generally defined between the distal end 971 of the tip 970 and the skin surface being treated. Therefore, according to some embodiments, the lip member 977 extends above the top of the protruding members 980 so that the protruding members are within the enclosed space during a treatment procedure. In other embodiments, the top surface of the lip 977 is generally aligned with the top surface of or below the protruding members 980.
With reference to
As illustrated in
Moreover, the distal end 971 of the tip 970 can include one or more outlet openings 984 through which exfoliated skin, spent serums, other waste liquids, fluids and other materials and/or the like can be removed. In the embodiment illustrated in
In some embodiments, once the distal end 971 of a tip 970 is positioned against the skin being treated, an enclosed space can be created between the skin surface and tip, generally along the interior of a peripheral lip member or other ridge. Therefore, as a vacuum or another suction source is generated in the handpiece assembly, exfoliated skin, spent serum, other fluids and/or other materials can be removed away from the tip 970. At the same time, the delivery stem 974 of the tip 970 and any other conduit or space that is in fluid communication with it may also be subjected to a suction force. Consequently, serums, other fluids and/or other treatment materials can be advantageously transported to the distal end 971 of the tip 970 through one or more openings 982. As discussed, the tip 970 or variations thereof can comprise any combination of treatment elements and/or abrasive elements, as desired or required by a particular application.
Additional details regarding tips for any embodiments of a handpiece assembly disclosed herein can be found in U.S. patent application Ser. No. 11/392,348 (filed on Mar. 29, 2006 and published as U.S. Publication No. 2007/0156124) and U.S. Provisional Patent Application No. 61/024,504 (filed on Jan. 29, 2008), the entireties of both of which are hereby incorporated by reference herein.
With continued reference to
As discussed herein with reference to
In any of the embodiments disclosed herein, including the one illustrated in
Another embodiment of a skin treatment system 1100 comprising a handpiece assembly 1110, a base member 1130 and a waste cartridge 1140 is illustrated in
With continued reference to
According to another embodiment, a handpiece assembly can be configured to be used in a shower or in other wet or high moisture conditions. Thus, in some arrangements, the handpiece assembly is waterproof and/or water resistant. In such embodiments, the pump or other fluid transfer device can be driven by electrical power, by water pressure (e.g., one or more connections to running water), by pneumatic power and/or any other method or device. It will be appreciated that such alternative methods or devices of operating a pump or other fluid transfer device can be used with respect to any other embodiment disclosed herein.
Some or all of the embodiments disclosed herein can be particularly useful for less expensive and/or simpler microdermabrasion systems. In some embodiments, such systems can target the home consumer market.
In any of the embodiments described and/or illustrated herein, or variations thereof, treatment fluids and/or other materials can be delivered to the tip of a handpiece assembly using one or more ways. For example, in some embodiments, serums or other substances can be delivered through a supply canister or fluid bottle. Such serums, compositions, other fluids or substances can be pre mixed so that they are delivered to the tip and the skin unmodified or substantially unmodified.
In other embodiments, serums, fluids, gels or other materials can be in the form of a pack container dry granular material, viscous gels and/or the like. Such packs can be mixed with water or some other fluid by a user to a desired concentration. In other embodiments, one or more treatment materials can be impregnated or otherwise embedded into the tips of the handpiece assemblies. Thus, such materials (e.g., powers, solids, gels, etc.) can advantageously dissolve when they contact water, saline or some other liquid. In still other embodiments, the treatment materials can be contained within a capsule, tablet or other enclosure. Such enclosures can be configured to dissolve when placed in water or some other fluid. Therefore, in some embodiments, a user may be required to place a capsule, the contents of a pack or some other materials into a canister and add water or other fluid before use.
In some embodiments, one or more serums or other substances can be delivered to the treatment surface of a handpiece assembly to treat a particular skin condition. For example, the system can be used to treat acne, dry or oily skin, fine lines, sun-damaged skin, other skin diseases or disorders and/or like.
In some embodiments, the serums, other materials and/or a combination of such serums or other materials can be utilized for the treatment of substantially most or all skin types. For example, such serums and/or other materials can be used when the handpiece assembly exfoliates skin.
In another embodiment, the serums, other materials and/or a combination of such serums or other materials can be used during a follow-up (e.g., secondary, tertiary, etc.) or finish treatment step. For example, such serums and/or other materials can be used to hydrate the skin and/or lighten treat skin damage, either in lieu of or in addition to exfoliating skin. In such embodiments, the serums and/or other materials can comprise anti-oxidants, hyaluronic acid and/or the like.
In yet other embodiments, the serums, other materials and/or a combination of such serums or other materials can be used to target acne or oily skin conditions. It will be appreciated that other serums, other materials and/or combinations of such serums or other materials can be used to target one or more types of skin conditions or treatments. Further, a particular treatment procedure can utilize one, two or more of such serums or other materials during various treatment phases (e.g., exfoliation, finish or polishing treatment, etc.).
In some embodiments, one or more kits can be developed that target a specific type of user, skin condition, desired result and/or the like. For example, such a kit can comprise serums and/or other materials that target teenage acne. As discussed, the serums and/or other materials contained in such kits can be in one or more different forms, such as, for example, liquids, gels, other fluids, powders, solids and/or the like. In some embodiments, such serums and/or other materials can be configured for immediate use. Alternatively, a particular amount of water, saline or other liquids, other dilution or dissolving agents and/or the like may need to be added to the serums and/or other materials to get them to a usable state.
In addition, depending on who the target user is (e.g., teenagers, adults, etc.) and/or how severe a particular condition is, the concentration or strength of the serums and/or other materials can be varied. For example, for younger users, a kit directed at acne treatment can comprise lower concentrations of serums and/or other materials. By way of another example, kits comprising higher concentrations or strengths of serums and/or other materials can be used to treat oily skin or acne in adults. In another embodiment, a kit can be developed to target users whose skin is generally typical (e.g., the users' skin is not abnormally dry or oily, the users do not have excessive amount of acne or scarring, etc.).
As discussed, the kits can include one, two or more different types of treatment combinations. For example, a kit can comprise a first combination of serum(s) and/or other material(s) that is intended to target the exfoliation of skin. The same kit may include a second treatment combination that can be used in a follow-up treatment to treat oily skin or the like. In other embodiments, however, a kit can comprise more or fewer treatment combinations, as desired or required by a particular skin treatment procedure.
The articles, devices, assemblies, systems and/or other items disclosed herein may be formed through any suitable means. The various methods and techniques described above provide a number of ways to carry out the invention. Of course, it is to be understood that not necessarily all objectives or advantages described may be achieved in accordance with any particular embodiment described herein. Thus, for example, those skilled in the art will recognize that the methods may be performed in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other objectives or advantages as may be taught or suggested herein.
Furthermore, the skilled artisan will recognize the interchangeability of various features from different embodiments disclosed herein. Similarly, the various features and steps discussed above, as well as other known equivalents for each such feature or step, can be mixed and matched by one of ordinary skill in this art to perform methods in accordance with principles described herein. Additionally, the methods which are described and illustrated herein are not limited to the exact sequence of acts described, nor are they necessarily limited to the practice of all of the acts set forth. Other sequences of events or acts, or less than all of the events, or simultaneous occurrence of the events, may be utilized in practicing the embodiments of the invention.
Although the invention has been disclosed in the context of certain embodiments and examples, it will be understood by those skilled in the art that the invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and obvious modifications and equivalents thereof. Accordingly, it is not intended that the invention be limited, except as by the appended claims.
This application claims the priority benefit under 35 U.S.C. §119(e) of U.S. Provisional Application No. 61/019,196, filed Jan. 4, 2008 and U.S. Provisional Application No. 61/022,201, filed Jan. 18, 2008, the entireties of which are hereby incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
2608032 | Garver | Aug 1952 | A |
2701559 | Cooper | Feb 1955 | A |
2712823 | Kurtin | Jul 1955 | A |
2867214 | Wilson | Jan 1959 | A |
2881763 | Robbins | Apr 1959 | A |
2921585 | Schumann | Jan 1960 | A |
3085573 | Meyer et al. | Apr 1963 | A |
3214869 | Stryker | Nov 1965 | A |
3476112 | Elstein | Nov 1969 | A |
3574239 | Sollerud | Apr 1971 | A |
3715838 | Young et al. | Feb 1973 | A |
3948265 | Al Ami | Apr 1976 | A |
3964212 | Karden | Jun 1976 | A |
4121388 | Wilson | Oct 1978 | A |
4155721 | Fletcher | May 1979 | A |
4182329 | Smith et al. | Jan 1980 | A |
4203431 | Abura et al. | May 1980 | A |
4216233 | Stein | Aug 1980 | A |
4378804 | Cortese | Apr 1983 | A |
4560373 | Sugino et al. | Dec 1985 | A |
4646480 | Williams | Mar 1987 | A |
4646482 | Chitjian | Mar 1987 | A |
4676749 | Mabille | Jun 1987 | A |
4706676 | Peck | Nov 1987 | A |
4754756 | Shelanski | Jul 1988 | A |
4757814 | Wang et al. | Jul 1988 | A |
4764362 | Barchas | Aug 1988 | A |
4795421 | Blasius, Jr. et al. | Jan 1989 | A |
4886078 | Shiffman | Dec 1989 | A |
4887994 | Bedford | Dec 1989 | A |
4900316 | Yamamoto | Feb 1990 | A |
4917086 | Feltovich et al. | Apr 1990 | A |
4957747 | Stiefel | Sep 1990 | A |
5006004 | Dirksing et al. | Apr 1991 | A |
5006339 | Bargery et al. | Apr 1991 | A |
5012797 | Liang et al. | May 1991 | A |
5035089 | Tillman et al. | Jul 1991 | A |
5037431 | Summers et al. | Aug 1991 | A |
5037432 | Molinari | Aug 1991 | A |
5100412 | Rosso | Mar 1992 | A |
5119839 | Rudolph | Jun 1992 | A |
5122153 | Harrel | Jun 1992 | A |
5207234 | Rosso | May 1993 | A |
5222956 | Waldron | Jun 1993 | A |
5242433 | Smith et al. | Sep 1993 | A |
5254109 | Smith et al. | Oct 1993 | A |
5368581 | Smith et al. | Nov 1994 | A |
5417674 | Smith et al. | May 1995 | A |
5460620 | Smith et al. | Oct 1995 | A |
5470323 | Smith et al. | Nov 1995 | A |
5562642 | Smith et al. | Oct 1996 | A |
5611687 | Wagner | Mar 1997 | A |
5674235 | Parisi | Oct 1997 | A |
5676643 | Cann et al. | Oct 1997 | A |
5676648 | Henley | Oct 1997 | A |
5683971 | Rose et al. | Nov 1997 | A |
5759185 | Grinberg | Jun 1998 | A |
5779519 | Oliver | Jul 1998 | A |
5800446 | Banuchi | Sep 1998 | A |
5807353 | Schmitz | Sep 1998 | A |
5810842 | Di Fiore et al. | Sep 1998 | A |
5813416 | Rudolph | Sep 1998 | A |
5846215 | Zygmont | Dec 1998 | A |
5848998 | Marasco, Jr. | Dec 1998 | A |
5873881 | McEwen et al. | Feb 1999 | A |
5879323 | Henley | Mar 1999 | A |
5882201 | Salem | Mar 1999 | A |
5885260 | Mehl, Sr. et al. | Mar 1999 | A |
5908401 | Henley | Jun 1999 | A |
5919152 | Zygmont | Jul 1999 | A |
5971999 | Naldoni | Oct 1999 | A |
6019749 | Fields et al. | Feb 2000 | A |
6024733 | Eggers et al. | Feb 2000 | A |
6027402 | Oliver | Feb 2000 | A |
6039745 | Di Fiore et al. | Mar 2000 | A |
6042552 | Cornier | Mar 2000 | A |
6080165 | DeJacma | Jun 2000 | A |
6080166 | McEwen et al. | Jun 2000 | A |
6090085 | Mehl, Sr. et al. | Jul 2000 | A |
6136008 | Becker et al. | Oct 2000 | A |
6139553 | Dotan | Oct 2000 | A |
6139554 | Karkar et al. | Oct 2000 | A |
6142155 | Rudolph | Nov 2000 | A |
6149634 | Bernabei | Nov 2000 | A |
6162232 | Shadduck | Dec 2000 | A |
6183451 | Mehl, Sr. et al. | Feb 2001 | B1 |
6183483 | Chang | Feb 2001 | B1 |
6231593 | Meserol | May 2001 | B1 |
6238275 | Metcalf et al. | May 2001 | B1 |
6241739 | Waldron | Jun 2001 | B1 |
6264666 | Coleman et al. | Jul 2001 | B1 |
6283978 | Cheski et al. | Sep 2001 | B1 |
6299620 | Shadduck | Oct 2001 | B1 |
6306119 | Weber et al. | Oct 2001 | B1 |
6368333 | Bernabei et al. | Apr 2002 | B2 |
6387103 | Shadduck | May 2002 | B2 |
6410599 | Johnson | Jun 2002 | B1 |
RE37796 | Henley | Jul 2002 | E |
6414032 | Johnson | Jul 2002 | B1 |
6420431 | Johnson | Jul 2002 | B1 |
6423078 | Bays et al. | Jul 2002 | B1 |
6423750 | Johnson | Jul 2002 | B1 |
6471712 | Burres | Oct 2002 | B2 |
6477410 | Henley et al. | Nov 2002 | B1 |
6488646 | Zygmont | Dec 2002 | B1 |
6494856 | Zygmont | Dec 2002 | B1 |
6500183 | Waldron | Dec 2002 | B1 |
6527783 | Ignon | Mar 2003 | B1 |
6535761 | Bernabei | Mar 2003 | B2 |
6540757 | Hruska et al. | Apr 2003 | B1 |
6562013 | Marasco, Jr. | May 2003 | B1 |
6564093 | Ostrow et al. | May 2003 | B1 |
6565535 | Zaias et al. | May 2003 | B2 |
6582442 | Simon et al. | Jun 2003 | B2 |
6592595 | Mallett et al. | Jul 2003 | B1 |
6629983 | Ignon | Oct 2003 | B1 |
6641591 | Shadduck | Nov 2003 | B1 |
6645184 | Zelickson et al. | Nov 2003 | B1 |
6652888 | Rhoades | Nov 2003 | B2 |
6673081 | Tavger et al. | Jan 2004 | B1 |
6673082 | Mallett et al. | Jan 2004 | B2 |
6685853 | Angelopoulos et al. | Feb 2004 | B1 |
6687537 | Bernabei | Feb 2004 | B2 |
6695853 | Karasiuk | Feb 2004 | B2 |
6735470 | Henley et al. | May 2004 | B2 |
6743215 | Bernabei | Jun 2004 | B2 |
6869611 | Kligman et al. | Mar 2005 | B1 |
6905487 | Zimmerman | Jun 2005 | B2 |
6911031 | Muldner | Jun 2005 | B2 |
6924649 | Knoedgen | Aug 2005 | B2 |
6926681 | Ramey et al. | Aug 2005 | B1 |
6942649 | Ignon et al. | Sep 2005 | B2 |
7001355 | Nunomura et al. | Feb 2006 | B2 |
7004933 | McDaniel | Feb 2006 | B2 |
7044938 | La Bianco et al. | May 2006 | B2 |
7069073 | Henley et al. | Jun 2006 | B2 |
7083580 | Bernabei | Aug 2006 | B2 |
7087063 | Carson et al. | Aug 2006 | B2 |
7094252 | Koop | Aug 2006 | B2 |
7115275 | Clarot et al. | Oct 2006 | B2 |
7135011 | Powers et al. | Nov 2006 | B2 |
7153311 | Chung | Dec 2006 | B2 |
7197359 | Tokudome et al. | Mar 2007 | B1 |
7198623 | Fischer et al. | Apr 2007 | B2 |
7276051 | Henley et al. | Oct 2007 | B1 |
7314326 | Rosenberg | Jan 2008 | B2 |
7316657 | Kleinhenz et al. | Jan 2008 | B2 |
7318828 | Revivo | Jan 2008 | B1 |
7320691 | Pilcher et al. | Jan 2008 | B2 |
7320801 | Kelly | Jan 2008 | B2 |
7354423 | Zelickson et al. | Apr 2008 | B2 |
7364565 | Freeman | Apr 2008 | B2 |
7427273 | Mitsui | Sep 2008 | B2 |
7458944 | Liste et al. | Dec 2008 | B2 |
7476205 | Erdmann | Jan 2009 | B2 |
7477938 | Sun et al. | Jan 2009 | B2 |
7482314 | Grimes et al. | Jan 2009 | B2 |
7489989 | Sukhanov et al. | Feb 2009 | B2 |
7507228 | Sun et al. | Mar 2009 | B2 |
7582067 | Van Acker | Sep 2009 | B2 |
7597900 | Zimmer et al. | Oct 2009 | B2 |
7597901 | Clarot et al. | Oct 2009 | B2 |
7658742 | Karasiuk | Feb 2010 | B2 |
7678120 | Shadduck | Mar 2010 | B2 |
7789886 | Shadduck | Sep 2010 | B2 |
7837695 | Hart et al. | Nov 2010 | B2 |
7951156 | Karasiuk | May 2011 | B2 |
8025669 | David et al. | Sep 2011 | B1 |
20010049511 | Coleman et al. | Dec 2001 | A1 |
20020058952 | Weber et al. | May 2002 | A1 |
20020107527 | Burres | Aug 2002 | A1 |
20020133110 | Citow | Sep 2002 | A1 |
20030012415 | Cossel | Jan 2003 | A1 |
20030060834 | Muldner | Mar 2003 | A1 |
20030097139 | Karasiuk | May 2003 | A1 |
20030187462 | Chang | Oct 2003 | A1 |
20030208159 | Ignon et al. | Nov 2003 | A1 |
20030212127 | Glassman et al. | Nov 2003 | A1 |
20030212415 | Karasiuk | Nov 2003 | A1 |
20040092895 | Harmon | May 2004 | A1 |
20040166172 | Rosati et al. | Aug 2004 | A1 |
20040236291 | Zelickson et al. | Nov 2004 | A1 |
20040243149 | Lee, Jr. | Dec 2004 | A1 |
20040267285 | Chang | Dec 2004 | A1 |
20050037034 | Rhoades | Feb 2005 | A1 |
20050038448 | Chung | Feb 2005 | A1 |
20050084509 | Bernstein | Apr 2005 | A1 |
20050148958 | Rucinski | Jul 2005 | A1 |
20050203111 | David | Sep 2005 | A1 |
20050283176 | Law | Dec 2005 | A1 |
20060002960 | Zoeteweij | Jan 2006 | A1 |
20060200099 | La Bianco et al. | Sep 2006 | A1 |
20060200172 | Shadduck | Sep 2006 | A1 |
20060200173 | Shadduck | Sep 2006 | A1 |
20060212029 | Arcusa Villacampa et al. | Sep 2006 | A1 |
20060253125 | Ignon | Nov 2006 | A1 |
20070065515 | Key | Mar 2007 | A1 |
20070088371 | Karasiuk | Apr 2007 | A1 |
20070154502 | Hattendorf et al. | Jul 2007 | A1 |
20070156124 | Ignon et al. | Jul 2007 | A1 |
20070178121 | First et al. | Aug 2007 | A1 |
20070208353 | Shadduck | Sep 2007 | A1 |
20070114904 | Spindler | Oct 2007 | A1 |
20070239173 | Khalaj | Oct 2007 | A1 |
20080027328 | Klopotek et al. | Jan 2008 | A1 |
20080091179 | Durkin et al. | Apr 2008 | A1 |
20080119781 | King | May 2008 | A1 |
20080132914 | Bossard et al. | Jun 2008 | A1 |
20080139974 | Da Silva | Jun 2008 | A1 |
20080193493 | Rhoades | Aug 2008 | A1 |
20080200861 | Shalev et al. | Aug 2008 | A1 |
20080214987 | Xu | Sep 2008 | A1 |
20080215068 | Hart et al. | Sep 2008 | A1 |
20080287864 | Rosenberg | Nov 2008 | A1 |
20080300529 | Reinstein | Dec 2008 | A1 |
20090048557 | Yeshurun et al. | Feb 2009 | A1 |
20090053390 | Sakou et al. | Feb 2009 | A1 |
20090099091 | Hantash | Apr 2009 | A1 |
20090099093 | Hantash | Apr 2009 | A1 |
20090124985 | Hasenoehrl et al. | May 2009 | A1 |
20090177171 | Ignon et al. | Jul 2009 | A1 |
20090192442 | Ignon et al. | Jul 2009 | A1 |
20090222023 | Boone, III et al. | Sep 2009 | A1 |
20100045427 | Boone, III et al. | Feb 2010 | A1 |
20100049177 | Boone, III et al. | Feb 2010 | A1 |
20110054490 | Hart | Mar 2011 | A1 |
20110082415 | Ignon et al. | Apr 2011 | A1 |
20120022435 | Ignon et al. | Jan 2012 | A1 |
Number | Date | Country |
---|---|---|
34 21 390 | Dec 1985 | DE |
234 608 | Apr 1986 | DE |
10 2004 01581 | Nov 2005 | DE |
0 258 901 | Sep 1987 | EP |
0 564 392 | Mar 1993 | EP |
553 076 | Dec 1956 | IT |
118 49 22 | Mar 1985 | IT |
WO 03073917 | Sep 2003 | WO |
WO 2006018731 | Feb 2006 | WO |
Number | Date | Country | |
---|---|---|---|
20090177171 A1 | Jul 2009 | US |
Number | Date | Country | |
---|---|---|---|
61019196 | Jan 2008 | US | |
61022201 | Jan 2008 | US |